Close Menu

Quest

Data Breach at Quest

Almost 12 million Quest Diagnostics customers may have had their personal information exposed in a data breach, CNBC reports.

A study of 10 commercial labs offering NIPT in the US found that none followed all recommendations for reporting results and informing patients and providers.

The development is a positive for plaintiff Amy Williams, who has said she hopes her lawsuit will spur greater accountability and transparency among genetic testing labs.

The groups will conduct a study evaluating the benefits of targeted next-generation sequencing in the diagnosis and care of infants with genetic disorders.

Case Continues

The Post and Courier discusses a South Carolina court's decision in the Williams v Quest case.

One woman affected by Ireland's cervical cancer scandal has settled with the Irish health service and US-based Quest Diagnostics.

Though the South Carolina Supreme Court said Quest was a healthcare provider, Williams can try to keep her case alive by arguing she's alleging ordinary negligence.

The court's ruling that Quest was acting as a licensed healthcare provider could affect the statute of limitations in the suit.

The prospective analysis suggests that the approach could help clinicians identify patients at risk of a stroke who could benefit from anticoagulant treatment.

The companies are accelerating the pace of an existing collaboration with the goal of detecting SMA "2+0" carrier status.

Pages

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.